Cartesian Therapeutics (RNAC) Operating Expenses (2015 - 2026)
Cartesian Therapeutics (RNAC) posted quarterly Operating Expenses of $26.6 million for Q1 2026, up 15.61% year-over-year from $23.0 million in Q1 2025, and down 66.61% quarter-over-quarter from $79.6 million in Q4 2025.
Cartesian Therapeutics (RNAC) Operating Expenses (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported Operating Expenses for 12 consecutive years, with $26.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 15.61% year-over-year to $26.6 million; the TTM figure through Mar 2026 stood at $149.8 million (up 72.95% YoY), while the FY2025 annual figure was $146.2 million, up 76.55% from the prior year.
- Operating Expenses eased to $26.6 million in Q1 2026 per RNAC's latest filing, from $79.6 million in the prior quarter.
- Across five years, Operating Expenses topped out at $79.6 million in Q4 2025 and bottomed at $18.0 million in Q3 2024.
- Historically, Operating Expenses has averaged $27.3 million across 5 years, with a median of $23.2 million in 2022.
- Annual changes were most pronounced in 2024 — Operating Expenses plunged 41.76% — and 2025, when it surged 206.43%.
- Cartesian Therapeutics' Operating Expenses stood at $25.3 million in 2022, then surged by 76.34% to $44.6 million in 2023, then slumped by 41.76% to $26.0 million in 2024, then soared by 206.43% to $79.6 million in 2025, then plunged by 66.61% to $26.6 million in 2026.
- Business Quant data shows RNAC's Operating Expenses at $26.6 million in Q1 2026, $79.6 million in Q4 2025, and $21.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Cartesian Therapeutics | 265.54 Mn | 265.54 Mn | - | 29.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.16 Mn |
| Mar 31, 2026 | 26.58 Mn |
| Dec 31, 2025 | 79.59 Mn |
| Sep 30, 2025 | 21.52 Mn |
| Jun 30, 2025 | 22.11 Mn |
| Mar 31, 2025 | 22.99 Mn |
| Dec 31, 2024 | 25.97 Mn |
| Sep 30, 2024 | 17.96 Mn |
| Jun 30, 2024 | 19.69 Mn |
| Mar 31, 2024 | 19.19 Mn |
| Dec 31, 2023 | 44.60 Mn |
| Sep 30, 2023 | 19.62 Mn |
| Jun 30, 2023 | 23.89 Mn |
| Mar 31, 2023 | 24.32 Mn |
| Dec 31, 2022 | 25.29 Mn |
| Sep 30, 2022 | 22.31 Mn |
| Jun 30, 2022 | 25.41 Mn |
| Mar 31, 2022 | 23.23 Mn |
| Dec 31, 2021 | 25.86 Mn |
| Sep 30, 2021 | 26.40 Mn |